Data Management has been a hotbed for development and innovation, correlating primarily with
the changing digital landscape. Clinical trial management has been significantly impacted, with the
electronic data capture and GDPR-compliance-led industry now unrecognisable from the paper-document administration methods of the past. This development process extends beyond COVID-19 and has a
noticeable impact on clinical trials.
Bayer Leaps to invests €1.3bn externally
Latest NewsGerman Bayer AG has announced it will channel at least €1.3b by the end of 2024 in its investment arm ‘Leaps by Bayer’.
IZB start-up AMSilk GmbH
Sponsored PublicationsBuilding a sustainable future this is what drives us. We are passionate about making smart biotech materials part of everyday life. We believe nature offers better alternatives to existing materials with biofabricated technologies previously unimaginable – enabling our customers to make a true change.
Avantium closes financing for FDCA plant
Latest NewsAvantium NV has reached financial close for the construction of a 5,000 ton FDCA plant, one of the two monomers needed to make fossil-free, recyclable PEF.
Anders Tegnell joins WHO
AppointmentsThe Swedish chief epidemiologist Anders Tegnell plans to move to the World Health Organisation (WHO) in Geneva.
Novo Holdings co-leads €40m Qure.ai financing
Latest NewsDeep learning medical imaging specialist Qure.ai raises $40m from healthcare investors Novo Holdings and HealthQuad
After the setback, what's next for biotech stocks?
OpinionWhile the Nasdaq Biotechnology index saw a huge uplift during the pandemic (+ 77% since March 2020 until reaching a peak in August 2021), it lost 27% during the last six months vs a 11%/4% decline for the Nasdaq Composite and the S&P 500, respectively
Sanofi and IGM Biosciences Inc. in $6.15bn deal
Latest NewsSanofi and IGM Biosciences have entered into a broad antibody discovery collaboration that could bring in IGM $6bn if all milestones are met.
XNK Therapeutics AB raises €12.75m
Latest NewsXNK Therapeutics AB has secured a private placement of €12.75m led by Flerie Invest AB to finance Phase II development of CellProtect + Isatuximab in multiple myeloma.
Automated workflow
Sponsored PublicationsThe SARS-CoV-2 virus global outbreak generated a need for fast and reliable large-scale testing. One of the main bottlenecks of the PCR test is the laborious and time-consuming molecular method for viral genetic material extraction. BioEcho Life Sciences, together with Hamilton and the German diagnostics laboratory Labor Dr. Fenner und Kollegen’ developed an automated workflow for 96- and 48-well plate formats.
Mastering the data revolution of clinical trials
BackgroundData Management has been a hotbed for development and innovation, correlating primarily with
the changing digital landscape. Clinical trial management has been significantly impacted, with the
electronic data capture and GDPR-compliance-led industry now unrecognisable from the paper-document administration methods of the past. This development process extends beyond COVID-19 and has a
noticeable impact on clinical trials.